Aptar CSP Technologies

Aptar CSP Technologies is the premier active material science solutions expert that transforms ideas into market opportunities, accelerates and de-risks the product development process, and provides complete solutions that improve consumers' and patients' lives. Based on breakthrough science, the company's proprietary 3-Phase Activ-Polymer technology enables the development of innovative, highly engineered material science based solutions to meet a broad range of product stability needs across six key therapeutic areas. The company serves multiple markets including oral solid dose pharmaceuticals, probiotics and nutraceuticals, dermal drug delivery, medical devices and implants, diagnostics, drug delivery systems, and food protection. Aptar CSP Technologies offers comprehensive development services through their XCELERATE program, including feasibility assessment and compatibility studies, solution design and development, extractables and finished product characterization testing, stability studies and validation, design/tooling validation and human factor studies, commercial and regulatory submission readiness, and market launch support. The company operates 4 production sites located in 3 countries across 3 continents, employs over 500 people, holds 500+ patents granted worldwide, and reinvests 5% of annual revenue in sustainability and R&D projects. Their technology is used by the world's leading brands and improves thousands of people's lives every minute. Notable recent developments include their N-Sorb nitrosamine mitigation solution being accepted to the US FDA's Emerging Technology Program and the launch of a cGMP early-stage clinical manufacturing site for tablet and capsule-based drug products.